Establishment Labs Holdings Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Establishment Labs Holdings Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: For every $100 of sales, $54 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $32 tied up three years earlier. More money tied up than 95% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-4.2×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 56% of Healthcare companies in United States.
Cash Locked Ratio
$54For every $100 of sales, $54 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $32 tied up three years earlier.
More money tied up than 95% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
$49Sales grew 31% in 3 years; of every extra $100 of sales, $49 became extra profit.
Higher than 70% of Healthcare companies in United States.
Asset Productivity Ratio
+31% / +69%In 3 years sales changed by +31% while total assets changed by +69%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-4.1×Operating cash was negative last year, while some debt falls due within a year.
Higher than 60% of Healthcare companies in United States.
Cash Cushion Ratio
−10%Debt, after subtracting cash, equals 10% of its market value (net debt).
Lower than 78% of Healthcare companies in United States.
Tangible Assets Ratio
97%Of every $100 the company owns, $97 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 79% of Healthcare companies in United States.
Tangible Net Worth Ratio
53%Of every $100 of net worth, $53 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 51% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Establishment Labs Holdings Inc. made a loss over the last year. Establishment Labs Holdings Inc. owes $0.94 for every $1 it owns. Establishment Labs Holdings Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossEstablishment Labs Holdings Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
87.61The share price is 87.61 times Establishment Labs Holdings Inc.'s book value per share, higher than almost all Healthcare companies in United States.
Market cap
$1.9 BThe total market value of all of Establishment Labs Holdings Inc.'s shares at today's price (share price × number of shares), larger than 74% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$22 MWhat Establishment Labs Holdings Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.73Net worth divided by the number of shares. The share price of $63.52 is 87.6 times this, which is the P/B above.
Return on equity (ROE)
-175.3%Establishment Labs Holdings Inc. lost 175.3% of its shareholders' money over the last year, lower than 82% of Healthcare companies in United States.
Owes vs Owns
0.94×Establishment Labs Holdings Inc. owes $0.94 for every $1 it owns (high), higher than 85% of Healthcare companies in United States.
Dividend yield
NoneEstablishment Labs Holdings Inc. does not currently pay a dividend.
Revenue growth
+27%Revenue rose 27% in the year to Dec 2025, and grew 9% a year on average over 3 years.
Profit growth
LossEstablishment Labs Holdings Inc. made a loss in each of the last two years.
Profit margin
-24.2%Establishment Labs Holdings Inc. lost $24 for every $100 of revenue.
Interest cover
Not coveredEstablishment Labs Holdings Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtEstablishment Labs Holdings Inc. had $189 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Establishment Labs Holdings Inc.: $1.9 B ÷ $22 M (30 Jun 2026) = 87.6.
What is Establishment Labs Holdings Inc.'s return on equity?
Establishment Labs Holdings Inc. lost 175.3% of its shareholders' money over the last year, lower than 82% of Healthcare companies in United States.
How much does Establishment Labs Holdings Inc. owe compared with what it owns?
Establishment Labs Holdings Inc. owes $0.94 for every $1 it owns (high), higher than 85% of Healthcare companies in United States.
Does Establishment Labs Holdings Inc. pay a dividend?
No. Establishment Labs Holdings Inc. does not currently pay a dividend.
Is Establishment Labs Holdings Inc.'s revenue growing?
Revenue rose 27% in the year to Dec 2025, and grew 9% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.